Oruka Stock Is Now Up Nearly 700%. Here's What a $687,000 Insider Sale Could Mean

This biotech innovator in monoclonal antibody therapies reported a notable insider sale amid ongoing clinical-stage developments.

CryptoAlerta — análise de criptomoedas e mercado em tempo real